Related Experiment Video
Updated: Aug 29, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Combined DEX/CRH test among Japanese patients with major depression
Hiroshi Kunugi1, Takako Urushibara, Shinichiro Nanko
1Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1, Ogawahigashi, Kodaira, 187-8502, Tokyo, Japan. hkunugi@ncnp.go.jp
Insights
The dexamethasone (DEX)/CRH test effectively detects hypothalamus-pituitary-adrenal (HPA) axis abnormalities in Japanese major depressive disorder patients. This sensitive test shows differences in HPA axis function, potentially linking suicidal behavior to HPA axis dysfunction.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Clinical Diagnostics
Background:
- Hypothalamus-pituitary-adrenal (HPA) axis abnormalities are implicated in major depressive disorder (MDD).
- The combined dexamethasone (DEX)/corticotropin-releasing hormone (CRH) test is more sensitive than the conventional DEX suppression test for detecting HPA axis dysfunction.
- Limited data exists on DEX/CRH test results in Asian populations, particularly those with depression.
Purpose of the Study:
- To evaluate the sensitivity of the DEX/CRH test in detecting HPA axis abnormalities among Japanese patients diagnosed with major depression.
- To compare HPA axis responses between Japanese patients with major depression and healthy controls using the DEX/CRH test.
- To explore potential correlations between HPA axis abnormalities, suicidal history, and the DEX/CRH test results in depressed individuals.
Main Methods:
- The DEX/CRH test was administered to 20 inpatients with a major depressive episode and 30 healthy controls.
- Cortisol and ACTH (adrenocorticotropic hormone) responses were measured post-DEX/CRH administration.
- Participants were categorized into non-suppressor, intermediate suppressor, and suppressor groups based on cortisol response patterns.
Main Results:
- Japanese patients with major depression exhibited significantly increased cortisol responses compared to healthy controls.
- A significant difference in the distribution of cortisol response patterns (non-suppressor, intermediate, suppressor) was observed between patients and controls (P<0.01).
- ACTH responses showed a similar trend, and patients with a history of suicide attempts tended to display enhanced DEX/CRH test responses.
Conclusions:
- The DEX/CRH test is confirmed as a sensitive tool for identifying HPA axis abnormalities in Japanese individuals with major depression.
- The findings suggest a potential link between suicidal behavior and heightened HPA axis dysfunction in major depressive disorder.
- This study highlights the utility of the DEX/CRH test in a specific Asian population for understanding HPA axis dysregulation in depression.
Abstract:
There is compelling evidence for an important role of the hypothalamus-pituitary-adrenal (HPA) axis abnormalities in the pathophysiology of major depressive disorder. Growing evidence has suggested that the combined dexamethasone (DEX)/CRH test is much more sensitive than the conventional DEX suppression test in order to detect HPA axis abnormalities. However, little data is currently available on DEX/CRH results for Asian populations, which prompted us to examine the sensitivity of the DEX/CRH test among Japanese subjects with major depression. The DEX/CRH test was administered in 20 inpatients with major depressive episode and 30 healthy controls. Significantly increased cortisol responses were observed for the patients, compared to the controls. There was a substantial difference in the distribution of non-suppressor, intermediate suppressor, and suppressor, which were defined in terms of cortisol response, was observed between the patients and controls (10, 60, and 30% in the patients vs. 0, 27, and 73% in the controls, P<0.01). Responses of ACTH showed a trend in the same direction. Within the depressed patients, individuals with a history of attempted suicide, in particular, tended to have enhanced responses to the DEX/CRH test, compared to those without such a history. Our results confirmed that the DEX/CRH test is a sensitive test to detect HPA axis abnormalities among Japanese patients with major depression. In addition, a possible relationship between suicidal acts and enhanced HPA axis abnormalities was suggested.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
G Protein-coupled Receptors